Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase

Molecular Pharmacology

Volumn 54, Issue 2, 1998, Pages 280-290

  Neamati, Nouri ^a   Mazumder, Abhijit ^a   Sunder, Sanjay ^a   Owen, Joshua M ^a   Tandon, Manju ^b   Lown, J William ^b   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CONGOCIDINE; DIMINAZENE ACETURATE; DISTAMYCIN A DERIVATIVE; INDOLE DERIVATIVE; INTEGRASE; LEXITROPSIN; PENTAMIDINE; POLYAMIDE; SPERMIDINE; SPERMINE;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; PRIORITY JOURNAL; VIRUS GENE; VIRUS RESISTANCE;

EID: 0031820936     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.2.280     Document Type: Article

References (39)

1. Arts EJ and Wainberg MA (1996) Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob Agents Chemother 40:527-540.
2. Bouziane M, Cherny DI, Mouscadet JF, and Auclair C (1996) Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro. J Biol Chem 271:10359-10364.
3. Bushman FD, Engelman A, Palmer I, Wingfield P, and Craigie R (1993) Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci USA 90:3428-3432.
4. Carteau S, Mouscadet JF, Goulaouic H, Subra F, and Auclair C (1993) Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochem Biophys Res Commun 192:1409-1414.
5. Chow SA, Vincent KA, Ellison V, and Brown PO (1992) Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (Washington DC) 255:723-726.
6. De Clercq E (1995) Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. J Med Chem 38:2491-2517.
7. De Clercq E (1996) Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development. Med Res Rev 16:125-157.
8. Engelman A and Craigie R (1995) Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J Virol 69:5908-5911.
9. Engelman A, Mizuuchi K, and Craigie R (1991) HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67:1211-21.
10. Erickson JW and Burt SK (1996) Structural mechanisms of HIV drug resistance. Annu Rev Pharmacol Toxicol 36:545-571.
11. Fesen MR, Kohn KW, Leteurtre F, and Pommier Y (1993) Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci USA 90:2399-2403.
12. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, and Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 48:595-608.
13. Hazuda D, Felock P, Hastings J, Pramanik B, Wolfe A, Goodarzi G, Vora A, Brackmann K, and Grandgenett D (1997a) Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds. J Virol 71:807-811.
14. Hazuda DJ, Felock PJ, Hastings JC, Pramanik B, and Wolfe AL (1997b) Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J Virol 71:7005-7011.
15. Helene C (1998) Reading the minor groove. Nature (Lond) 391:436-438.
16. Johnson VA (1994) Combination therapy: more effective control of HIV type 1? AIDS Res Hum Retrov 10:907-912.
17. Katz RA and Skalka AM (1994) The retroviral enzymes. Annu Rev Biochem 63:133-173.
18. Kopka ML and Larsen TA (1992) Netropsin and the Lexitropsins (Propst CL and Perun TJ, eds) pp. 303-374, Marcel Dekker, New York.
19. Kopka ML, Yoon C, Goodsell D, and Pjura P (1985) The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc Natl Acad Sci USA 82:1376-1380.
20. Larder BA, Kemp SD, and Harrigan PR (1995) Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science (Washington DC) 269:696-699.
21. Lown JW (1988) Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes. Anti-Cancer Drug Design 3:25-40.
22. Lown JW (1994) DNA recognition by lexitropsins, minor groove binding agents. J Mol Recognit 7:79-88.
23. Lown JW, Krowicki KK, Balzarini J, Newman RA, and De Clercq E (1989) Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation. J Med Chem 32:2368-2375.
24. Mazumder A, Neamati N, Pilon AA, Sunder S, and Pommier Y (1996a) Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site: implications for the role of lysine 136 in DNA binding. J Biol Chem 271:27330-27338.
25. Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E, and Pommier Y (1997) Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem 40:3057-3063.
26. Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, Milne GW, Rice WG, Burke TR Jr, and Pommier Y (1996b) Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem 39:2472-2481.
27. Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Nicklaus MC, Milne GWA, Proksa B, and Pommier Y (1997a) Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J Med Chem 40:942-951.
28. Neamati N, Hong H, Sunder S, Milne GWA, and Pommier Y (1997b) Potent inhibitors of human immunodeficiency virus type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors. Mol Pharmacol 52:1041-1055.
29. Neamati N, Sunder S, and Pommier Y (1997c) Design and discovery of HIV-1 integrase inhibitors. Drug Discovery Today 2:487-498.
30. Nishiwaki E, Tanaka S, Lee H, and Shibuya M (1988) Efficient synthesis of oligo-N-methyl pyrrolecarboxamides and related compounds. Heterocycles 27:1945-1952.
31. Pommier Y, Pilon AA, Bajaj K, Mazumder A, and Neamati N (1997) HIV-1 integrase as a target for antiviral drugs. Antivir Chem Chemother 8:463-483.
32. Rice P, Craigie R, and Davies DR (1996) Retroviral integrases and their cousins. Curr Opin Struct Biol 6:76-83.
33. Schinazi RF (1991) Combined Chemotherapeutic Modalities for Viral Infections: Rationale and Clinical Potential (Chou TC and Rideout DC, eds) pp. 109-181, Academic Press, Orlando, FL.
34. Vink C, Yeheskiely E, van der Marel GA, van Boom JH, and Plasterk RH (1991) Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res 19:6691-8.
35. Wang W and Lown L (1992) Anti-HIV-1 activity of linked lexitropsins. J Med Chem 35:2890-2897.
36. Weislow OW, Riser R, Fine D, Bader J, Shoemaker RH, and Boyd MR (1989) New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity. J Natl Cancer Inst 81:577-586.
37. White S, Szewczyk JW, Turner JM, Baird EE, and Dervan PB (1998) Recognition of the four Watson-Crick pairs in the DNA minor groove by synthetic ligands. Nature (Lond) 391:468-470.
38. Zimmer C, Luke G, Birch-Hiershfeld E, Weiss R, Arcamone F, and Guschlbauer W (1983) Chain length dependent association of distamycin-type oligopeptides with AT and GC pairs in polydeoxynucleotide duplexes. Biochim Biophys Acta 741:15-22.
39. Zimmer C, Puschendorf B, Grunkicke H, Chandra P, and Venner H (1977) Influence of netropsin and distamycin A on the secondary structure and template activity of DNA. Eur J Biochem 21:269-278.